Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M2,636Revenue $M674Net Margin (%)16.6Z-Score7.2
Enterprise Value $M2,391EPS $1.5Operating Margin %15.4F-Score5
P/E(ttm))24.2Cash Flow Per Share $1.6Pre-tax Margin (%)20.3Higher ROA y-yN
Price/Book3.410-y EBITDA Growth Rate %0Quick Ratio2.2Cash flow > EarningsY
Price/Sales4.25-y EBITDA Growth Rate %50.0Current Ratio2.4Lower Leverage y-yN
Price/Cash Flow9.5y-y EBITDA Growth Rate %23.1ROA % (ttm)11.0Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)15.3Less Shares Outstanding y-yY
Payout Ratio %0Shares Outstanding M70.0ROI % (ttm)14.8Gross Margin Increase y-yY

Gurus Latest Trades with WX

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
WXRon Baron 2014-12-31 Add0.01%$32.91 - $38.69
($35.32)
$ 37.646%Add 24.81%251,500
WXRon Baron 2014-03-31 Add0.01%$32.58 - $39.86
($36.74)
$ 37.642%Add 25.90%210,500
WXJohn Hussman 2014-03-31 Sold Out -0.03%$32.58 - $39.86
($36.68)
$ 37.643%Sold Out0
WXJohn Hussman 2013-12-31 Reduce-0.02%$26.52 - $38
($31.52)
$ 37.6416%Reduce -50.00%10,000
WXRon Baron 2013-12-31 Add0.02%$26.52 - $38
($31.52)
$ 37.6416%Add 883.53%167,200
WXJulian Robertson 2013-12-31 Sold Out -2.4%$26.52 - $38
($31.52)
$ 37.6416%Sold Out0
WXJulian Robertson 2013-09-30 Reduce-0.85%$20.23 - $28.48
($23.68)
$ 37.6437%Reduce -35.37%576,218
WXJohn Hussman 2013-09-30 Reduce-0.02%$20.23 - $28.48
($23.68)
$ 37.6437%Reduce -50.00%20,000
WXJulian Robertson 2013-06-30 Reduce-0.34%$16.94 - $21.54
($19.52)
$ 37.6448%Reduce -13.99%891,618
WXJohn Hussman 2013-03-31 Buy 0.03%$15.44 - $17.91
($16.53)
$ 37.6456%New holding40,000
WXJulian Robertson 2012-06-30 Add0.28%$13.37 - $14.84
($14.21)
$ 37.6462%Add 6.51%1,154,418
WXJulian Robertson 2012-03-31 Reduce-1.67%$11.43 - $15.39
($12.73)
$ 37.6466%Reduce -24.88%1,083,818
WXMario Gabelli 2011-12-31 Reduce-0.01%$10.78 - $13.92
($11.9)
$ 37.6468%Reduce -28.82%250,200
WXJulian Robertson 2011-09-30 Add1.9%$11.56 - $17.26
($14.19)
$ 37.6462%Add 38.60%1,442,806
WXJulian Robertson 2011-03-31 Add0.24%$15.07 - $18.49
($16.38)
$ 37.6456%Add 5.71%1,095,772
WXMario Gabelli 2011-03-31 Reduce-0.11%$15.07 - $18.49
($16.38)
$ 37.6456%Reduce -64.06%518,000
WXGeorge Soros 2011-03-31 Buy 0.05%$15.07 - $18.49
($16.38)
$ 37.6456%New holding250,000
WXJulian Robertson 2010-12-31 Add0.99%$16.05 - $17.72
($16.77)
$ 37.6455%Add 30.12%1,036,572
WXJulian Robertson 2010-09-30 Buy 4.58%$14.25 - $17.23
($15.47)
$ 37.6459%New holding796,621
WXMario Gabelli 2010-09-30 Add0.07%$14.25 - $17.23
($15.47)
$ 37.6459%Add 120.05%1,689,100
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

WX is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


WX: Insider Buys/Sells

Click Here for All Insider Trades.

No Insider Trades Found!

Press Releases about WX :

    Quarterly/Annual Reports about WX:

      News about WX:

      Articles On GuruFocus.com
      Baron Funds Comments on WuXi PharmaTech Feb 24 2014 
      Columbia Management's Top 5 New Buys Amid Buoyant Outlook Aug 12 2013 
      comment on WX Sep 15 2012 
      Stocks That Are Cheaper Than Julian Robertson Bought Jan 06 2012 
      Stocks That Julian Robertson Keeps Buying Dec 23 2011 
      Julian Robertson’s "smart idea, grounded on exhaustive research, followed by a big bet" Jun 24 2011 
      Julian Robertson’s Tiger Management Q1 Portfolio Update May 16 2011 
      Tiger Management Buys WX, CVC, THRX, Sells Apple Inc., Google Inc., Ebay Inc. Nov 15 2010 
      WuXi PharmaTech Will Focus U.S. Operations on Laboratory Testing Services Dec 09 2008 

      More From Other Websites
      Investigational New Drug Application for WuXi MedImmune's Monoclonal Antibody Accepted for Review by... Mar 27 2015
      Investigational New Drug Application for WuXi MedImmune's Monoclonal Antibody Accepted for Review by... Mar 27 2015
      Landmark deCODE Studies Demonstrate the Power of Truly Big Genomics for Improving Medicine Worldwide Mar 25 2015
      Falling Earnings Estimates Signal Weakness Ahead for WuXi PharmaTech (WX) - Tale of the Tape Mar 23 2015
      WuXi PharmaTech Slumps: WX Falls 6.4% in Session - Tale of the Tape Mar 16 2015
      S&P 500 Down Nearly 1% In Broad Stock Decline Mar 13 2015
      WuXi PharmaTech To Build New Cell Therapy Manufacturing Facility for CAR T Cells and Other Cancer... Mar 12 2015
      WuXi PharmaTech To Build New Cell Therapy Manufacturing Facility for CAR T Cells and Other Cancer... Mar 12 2015
      Stocks Drop On Rate-Hike Fears; Big Lots Up On Earnings Mar 06 2015
      Stocks Down In Afternoon; Miners, Utilities Take Hit Mar 06 2015
      Stocks Extend Losses At Midday; WuXi PharmaTech Dives Mar 06 2015
      Wuxi Pharmatech Cayman Inc Earnings Call scheduled for 8:00 am ET today Mar 06 2015
      WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2014 Results Mar 05 2015
      WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2014 Results Mar 05 2015
      Q4 2014 Wuxi Pharmatech Cayman Inc Earnings Release - After Market Close Mar 05 2015
      WuXi Congratulates TaiMed Biologics on Receiving Breakthrough Therapy Designation from U.S. FDA Feb 27 2015
      WuXi Congratulates TaiMed Biologics on Receiving Breakthrough Therapy Designation from U.S. FDA Feb 27 2015
      WuXi PharmaTech Enters into Syndicated Loan Agreement Feb 18 2015
      WuXi PharmaTech Enters into Syndicated Loan Agreement Feb 17 2015
      WuXi PharmaTech Schedules Fourth-Quarter 2014 Earnings Release Feb 13 2015

      Add Notes, Comments

      If you want to ask a question, or report a bug, please create a support ticket.

      User Comments

      No comment yet
      Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
      GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
      Free 7-day Trial
      FEEDBACK